sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Antimicrobial Resistance Market Size Study, By Drug Class, By Indication, By Mechanism of Action, and Regional Forecasts 2022-2032

Global Antimicrobial Resistance Market Size Study, By Drug Class, By...

Home / Categories / Healthcare
Global Antimicrobial Resistance Market Size Study, By Drug Class, By Indication, By Mechanism of Action, and Regional Forecasts 2022-2032
Global Antimicrobial Resistance Market Size...
Report Code
RO1/103/2818

Publish Date
13/Aug/2024

Pages
200
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Table of Contents
Chapter 1. Global Antimicrobial Resistance Market Executive Summary
1.1. Global Antimicrobial Resistance Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Indication
1.3.3. By Mechanism of Action
1.3.3. By Pathogen
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Antimicrobial Resistance Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antimicrobial Resistance Market Dynamics
3.1. Market Drivers
3.1.1. Misuse and Overuse of Antibiotics
3.1.2. Rising Prevalence of Resistant Bacterial Infections
3.1.3. Increasing Demand for Novel Antibiotics
3.2. Market Challenges
3.2.1. High Cost of Novel Antibiotics
3.2.2. Regulatory Hurdles in Antibiotic Development
3.3. Market Opportunities
3.3.1. Technological Advancements in Antibiotic Development
3.3.2. Increased Funding and Collaboration
Chapter 4. Global Antimicrobial Resistance Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Antimicrobial Resistance Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Antimicrobial Resistance Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Combination Therapies
5.2.2. Tetracyclines
5.2.3. Cephalosporins
5.2.4. Glycopeptides and Lipoglycopeptides
5.2.5. Oxazolidinones
5.2.6. Others
Chapter 6. Global Antimicrobial Resistance Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Antimicrobial Resistance Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Complicated Urinary Tract Infections (cUTI)
6.2.2. Blood Stream Infections
6.2.3. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
6.2.4. Hospital Acquired Bacterial Pneumonia and Ventilator Acquired Bacterial Pneumonia (HABP and VABP)
6.2.5. Community Acquired Pneumonia (CAP)
6.2.6. Others
Chapter 7. Global Antimicrobial Resistance Market Size & Forecasts by Mechanism of Action 2022-2032
7.1. Segment Dashboard
7.2. Global Antimicrobial Resistance Market: Mechanism of Action Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Protein Synthesis Inhibitors
7.2.2. Cell Wall Synthesis Inhibitors
7.2.3. Others
Chapter 8. Global Antimicrobial Resistance Market Size & Forecasts by Pathogen 2022-2032
8.1. Segment Dashboard
8.2. Global Antimicrobial Resistance Market: Pathogen Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Escherichia coli
8.2.2. Klebsiella pneumoniae
8.2.3. Pseudomonas aeruginosa
8.2.4. Staphylococcus aureus
8.2.5. Enterococcus Spp
8.2.6. Others
Chapter 9. Global Antimicrobial Resistance Market Size & Forecasts by Region 2022-2032
9.1. North America Antimicrobial Resistance Market
9.1.1. U.S. Antimicrobial Resistance Market
9.1.1.1. Drug Class breakdown size & forecasts, 2022-2032
9.1.1.2. Indication breakdown size & forecasts, 2022-2032
9.1.1.3. Mechanism of Action breakdown size & forecasts, 2022-2032
9.1.2. Canada Antimicrobial Resistance Market
9.2. Europe Antimicrobial Resistance Market
9.2.1. U.K. Antimicrobial Resistance Market
9.2.2. Germany Antimicrobial Resistance Market
9.2.3. France Antimicrobial Resistance Market
9.2.4. Spain Antimicrobial Resistance Market
9.2.5. Italy Antimicrobial Resistance Market
9.2.6. Rest of Europe Antimicrobial Resistance Market
9.3. Asia-Pacific Antimicrobial Resistance Market
9.3.1. China Antimicrobial Resistance Market
9.3.2. India Antimicrobial Resistance Market
9.3.3. Japan Antimicrobial Resistance Market
9.3.4. Australia Antimicrobial Resistance Market
9.3.5. South Korea Antimicrobial Resistance Market
9.3.6. Rest of Asia Pacific Antimicrobial Resistance Market
9.4. Latin America Antimicrobial Resistance Market
9.4.1. Brazil Antimicrobial Resistance Market
9.4.2. Mexico Antimicrobial Resistance Market
9.4.3. Rest of Latin America Antimicrobial Resistance Market
9.5. Middle East & Africa Antimicrobial Resistance Market
9.5.1. Saudi Arabia Antimicrobial Resistance Market
9.5.2. South Africa Antimicrobial Resistance Market
9.5.3. Rest of Middle East & Africa Antimicrobial Resistance Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Alkem Laboratories Ltd
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Innoviva, Inc.
10.3.3. Pfizer Inc.
10.3.4. Merck & Co., Inc.
10.3.5. Acurx Pharmaceuticals, Inc.
10.3.6. Basilea Pharmaceutica Ltd
10.3.7. Cumberland Pharmaceuticals Inc.
10.3.8. Wockhardt Limited
10.3.9. Paratek Pharmaceuticals, Inc.
10.3.10. Nabriva Therapeutics plc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com